$ cat ./records/began-the-annual-gates-foundation-letter-tracking-global-health-p-2009.txt
Began the annual Gates Foundation Letter — tracking global health progress
[RECORD.TXT] · cat --full
Gates and Melinda began publishing annual letters from the Gates Foundation reporting on the progress and challenges of their global health and development work. Modeled on Warren Buffett's annual shareholder letters, the annual letters became widely read documents in the global health and development field, covering topics from vaccine delivery logistics to teacher effectiveness to the measurement of extreme poverty. The letters have been credited with raising public awareness of neglected diseases and the progress of global health initiatives.
Source: https://www.gatesfoundation.org/ideas/annual-letters
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Invested $18 million in green super rice project with Chinese Academy of Agricultural Sciences
Next →
Microsoft Accused of Vote-Rigging to Push Its Document Format Through ISO
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.